Cardiovascular Device Update articles from June 2002

Cardiovascular Device Update archives from June 2002

Role of new heart failure devices debated by electrophysiologists.(biventricular pacing)(implantable cardioverter-defibrillator )
June 1, 2002... SAN DIEGO, California--In the past several years, there has been a rapidly growing realization that congestive heart failure (CHF) represents a huge health care problem and a massive market opportunity for both the pharmaceutical and the...

Study: no downside seen to ICDs trying pacing prior to shock. (NASPE notebook).(implantable cardioverter defibrillators, North American Society for Pacing and Electrophysiology)
June 1, 2002... A multicenter study presented during last month's North American Society for Pacing and Electrophysiology (NASPE; Natick, Massachusetts) meeting showed that, most of the time, ICDs could correct a person's dangerous, abnormal heart rhythms...

SCVIR a showcase for breakthroughs in catheter intervention.(Society of Cardiovascular & Interventional Radiology)
June 1, 2002... BALTIMORE, Maryland--The 27th annual scientific meeting of the Society of Cardiovascular & Interventional Radiology (SCVIR; Fairfax, Virginia), held here in April, provided an update on new advances in the diverse field of interventional...

Cord blood as source for transfusion needs. (Report from Europe).(stem cell therapy)(angiography)(revascularization)(stress testing)(synthetic protein)
June 1, 2002... New sources of red blood cells (RBCs) could radically improve the transfusion capacity of many hospitals, and Luc Douay and his team at Hopital Armand Trousseau and other hospitals in the Paris area have investigated the potential for producing...

Abbott Laboratories (Abbott Park, Illinois) said it has completed the acquisition of the cardiovascular stent business of Biocompatibles International (Farnham, UK) for $234.5 million in cash. (Acquisitions).(Brief Article)
June 1, 2002... * Abbott Laboratories (Abbott Park, Illinois) said it has completed the acquisition of the cardiovascular stent business of Biocompatibles International (Farnham, UK) for $234.5 million in cash. The acquisition includes the worldwide marketing,...

Cardiome Pharma (Vancouver, British Columbia) said it has exercised an option to acquire the rights from Ilex Oncology (San Antonio, Texas) to clinical trial data for oxypurinol (Oxyprim) for the treatment of symptomatic hyperuricemia (gout) in allopurinol-intolerant patients. (Acquisitions).(Brief Article)
June 1, 2002... * Cardiome Pharma (Vancouver, British Columbia) said it has exercised an option to acquire the rights from Ilex Oncology (San Antonio, Texas) to clinical trial data for oxypurinol (Oxyprim) for the treatment of symptomatic hyperuricemia (gout)...

Goodman (Nagoya, Japan), a developer and distributor of vascular interventional devices, has signed a definitive agreement to acquire Avantec Vascular (Sunnyvale, California). (Acquisitions).(Brief Article)
June 1, 2002... * Goodman (Nagoya, Japan), a developer and distributor of vascular interventional devices, has signed a definitive agreement to acquire Avantec Vascular (Sunnyvale, California). The acquisition is expected to close by January 2003. Avantec...

Radiance Medical Systems (Irvine, California) said that at a special meeting of its shareholders they approved the acquisition of Indologix (also Irvine). (Acquisitions).(Brief Article)
June 1, 2002... * Radiance Medical Systems (Irvine, California) said that at a special meeting of its shareholders they approved the acquisition of Endologix (also Irvine). The combined company, which will bear the Endologix name, will focus on the development...

Vascular Solutions (Minneapolis, Minnesota) acquired the Acolysis intravascular ultrasound business from the secured creditors of Angiosonics (Morrisville, North Carolina) for $1.5 million in cash. (Acquisitions).(Brief Article)
June 1, 2002... * Vascular Solutions (Minneapolis, Minnesota) acquired the Acolysis intravascular ultrasound business from the secured creditors of Angiosonics (Morrisville, North Carolina) for $1.5 million in cash. The Acolysis system is a CE-marked product...

AdvaMed changes its position on user fees. (Business Developments).(Advanced Medical Technology Association)
June 1, 2002... Although the final bill approved by the House and Senate and sent to President George Bush for his signature omitted such fees, the Advanced Medical Technology Association (AdvaMed; Washington) last month reversed its longstanding opposition to...

CardioComm Solutions (Victoria, British Columbia) has signed a worldwide distribution agreement with Phillips Medical Systems (Andover, Massachusetts) to sell CardioComm's Global ECG Management Systems (GEMS) for cardiac event monitoring. (Agreements).(Brief Article)
June 1, 2002... * CardioComm Solutions (Victoria, British Columbia) has signed a worldwide distribution agreement with Philips Medical Systems (Andover, Massachusetts) to sell CardioComm's Global ECG Management Systems (GEMS) for cardiac event monitoring. The...

CardioDynamics (San Diego, California) entered an agreement with Medtronic (Minneapolis, Minnesota) to evaluate the clinical utility of CardioDynamics' ICG technology in Medtronic's implantable devices for cardiac resynchronization therapy in heart failure patients, and the potential integration of the BioZ ICG Module with Medtronic instrumentation. (Agreements).(Brief Article)
June 1, 2002... * CardioDynamics (San Diego, California) entered an agreement with Medtronic (Minneapolis, Minnesota) to evaluate the clinical utility of CardioDynamics' ICG technology in Medtronic's implantable devices for cardiac resynchronization therapy in...

Medtronic (Minneapolis, Minnesota) and Ventrica (Fremont, California) have signed a distribution agreement under which Medtronic is the sole distributor of Ventrica's magnetic anastomotic connectors for use in coronary artery bypass graft surgery in Europe. (Agreements).(Brief Article)
June 1, 2002... * Medtronic (Minneapolis, Minnesota) and Ventrica (Fremont, California) have signed a distribution agreement under which Medtronic is the sole distributor of Ventrica's magnetic anastomotic connectors for use in coronary artery bypass graft...

Device tracking may add more costs. (Market Updates).
June 1, 2002... User fees (see Business Developments, page 17) are just one area that may eventually increase costs for medical device manufacturers. Another area will be in medical device tracking under new rules issued last month by the FDA. But the rules...

Advanced Stent Technologies. (Personnel File).(Brief Article)
June 1, 2002... * Advanced Stent Technologies (AST; Pleasanton, California) has named several new senior managers. Eitan Konstantino, PhD, has been named chief executive officer and chief operating officer. He previously was chief technical officer at ByPass...

Thomas Soukup has been named chief scientist for Synovis Interventional Solutions, a subsidiary of Bio-Vascular (both St. Paul, Minnesota). (Personnel File).(Brief Article)
June 1, 2002... * Thomas Soukup has been named chief scientist for Synovis Interventional Solutions, a subsidiary of Bio-Vascular (both St. Paul, Minnesota). Soukup is rejoining the company after serving as vice president of engineering for two years at Biomec...

MicroMed sets sights on destination therapy. (Product Pipeline).(Biotronik)(Cardima)(Coalescent Surgical)(Endovasc)(Escalon Medical)(Guidant )(Interleukin Genetics)(Medtronic)(Novoste)(Orbus Medical Technologies )(Rubicon Medical)(St. Jude Medical )
June 1, 2002... Filing yet another milestone in the still relatively new field of ventricular assist devices (VADs) was MicroMed (Houston, Texas). The company submitted an investigational device exemption (IDE) application with the FDA late last month for its...